rs781986930
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_198239.2(CCN6):c.1010G>A(p.Cys337Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000185 in 1,461,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_198239.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCN6 | NM_198239.2 | c.1010G>A | p.Cys337Tyr | missense_variant | 5/5 | ENST00000368666.7 | NP_937882.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCN6 | ENST00000368666.7 | c.1010G>A | p.Cys337Tyr | missense_variant | 5/5 | 1 | NM_198239.2 | ENSP00000357655 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251082Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135692
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461466Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727038
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Progressive pseudorheumatoid dysplasia Pathogenic:5
Likely pathogenic, criteria provided, single submitter | clinical testing | Suma Genomics, Suma Genomics | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | Feb 14, 2023 | The missense c.1010G>A(p.Cys337Tyr) variant in CCN6 gene has been reported in homozygous state in multiple individuals affected with Progressive pseudorheumatoid dysplasia (Madhuri V, et. al., 2016; Dalal A, et. al.,2012). The p.Cys337Tyr variant is reported with an allele frequency of 0.0004% in the gnomAD exomes database and is novel (not in any individuals) in 1000 Genomes database. This variant has been reported to the ClinVar database as Pathogenic (multiple submissions). The amino acid change p.Cys337Tyr in CCN6 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Cys at position 337 is changed to a Tyr changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 19, 2024 | Variant summary: CCN6 c.1010G>A (p.Cys337Tyr) results in a non-conservative amino acid change located in the Cystine knot, C-terminal domain (IPR006207) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.6e-06 in 1612800 control chromosomes. c.1010G>A has been reported in the literature as homozygous genotype in multiple individuals in one family affected with Progressive Pseudorheumatoid Dysplasia and this variant has been shown to segregate with disease (Dalal_2012). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 22987568). ClinVar contains an entry for this variant (Variation ID: 521955). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | Feb 27, 2019 | This variant is interpreted as a Pathogenic for Progressive pseudorheumatoid arthropathy of childhood, autosomal recessive. The following ACMG Tag(s) were applied: PM2 : Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PP1-Moderate : PP1 upgraded in strength to Moderate (PMID:22987568). PP3 : Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PM3-Very strong : PM3 upgraded in strength to Very Strong to account for multiple jnrelated homozygous and compound heterozygous probands (PMID:22987568; 27436824; 25988854). - |
Pathogenic, criteria provided, single submitter | clinical testing | Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India | May 09, 2022 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2017 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 337 of the WISP3 protein (p.Cys337Tyr). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This missense change has been observed in individuals with progressive pseudorheumatoid dysplasia (PMID: 22791401, 22987568, 23270760, 25988854, 32351055). It has also been observed to segregate with disease in related individuals. This variant is also known as c.1064G>A or C337T. ClinVar contains an entry for this variant (Variation ID: 521955). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt WISP3 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at